Menu-Order-AI taps into the GLP-1 shift | What to order of the menu?
Menu-Order-AI taps into the GLP-1 shift | What to order of the menu?
The rise of GLP-1 medication (prescription drugs that mimic a natural hormone to manage Type 2 diabetes and obesity by regulating appetite, increasing fullness, and controlling blood sugar) is changing the eating habits of millions of consumers worldwide. Reduced appetite, shifting preferences, and a focus on high-protein, lighter meals are shaping new choices at the table. Yet when dining out, practical guidance is often missing. That’s exactly where Menu-Order-AI comes in. The U.S.-based app helps users decide in real time what to order, tailored to their dietary needs and goals. With more than 110,000 downloads in just four months, demand for this kind of smart, in-the-moment support is clearly growing.
2 minutes read
From prescription to plate
While platforms like OpenTable help secure reservations and Uber gets diners to their destination, one key moment has long been overlooked: choosing from the menu itself. For users of GLP-1 medication, such as Ozempic, that decision can be particularly challenging. Patients may leave with a prescription, but without clear guidance on what to order when dining out.
Menu-Order-AI addresses this gap by offering real-time recommendations based on a restaurant menu. Users simply select a venue or scan a menu, and within seconds receive tailored suggestions aligned with their dietary needs: high-protein, low-carb, and GLP-1-friendly options.
Menu-Order-AI | A new decision layer in dining
According to its creators, the app introduces a new ‘decision layer’ within the dining experience. While other apps focus on meal planning or tracking consumption, Menu-Order-AI centers on the critical moment of choice. Its rapid growth reflects that positioning, surpassing 110,000 downloads within just four and a half months of launch.
At the same time, the company is expanding its footprint in restaurants through a QR code program. Guests scan a code and instantly receive three personalized dish recommendations, without requiring any changes to menus, POS systems, or staff workflows. A low-barrier solution tailored to a growing audience with specific dietary needs.
International rollout and a growing market
Menu-Order-AI is scaling rapidly, with sales teams operating across the United States, India, and Turkey, aiming for global adoption alongside the rise in GLP-1 usage. This development aligns with a broader trend that is also gaining traction in Europe. Our colleague Marjolein van Spronsen previously wrote a blog about the so-called ‘Ozempic menu’ and its impact on menu design and portion sizes, an early signal of how dining habits are evolving.
When will it reach the Netherlands?
The question is no longer if, but when this type of technology will enter the Dutch market. As more consumers adjust their eating habits due to GLP-1, the need for smart, real-time guidance like Menu-Order-AI is likely to grow. One thing is clear: digital tools are increasingly shaping what ends up on the plate.
Website: Menu-Order-AI
